marketscreener.com Analyst action
Oppenheimer Adjusts PT on Crescent Capital BDC to $14 From $16, Maintains Perform Rating
Oppenheimer has lowered its price target for Crescent Capital BDC (CCAP) to $14 from $16, while keeping a "Perform" rating on the stock. This adjustment comes shortly after B. Riley also revised its price target for CCAP to $12.50 from $13.50, maintaining a "Neutral" rating. The article also notes recent company activities, including earnings calls, dividend declarations, and …